According to a recently published report by Research Nester on “Rotavirus Vaccines Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the rotavirus vaccines market in terms of market segmentation by type, by end users and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The global rotavirus vaccine market is anticipated to record a CAGR of around 12.8% over the forecast period i.e. 2019-2027. The market is segmented by type & end users. The market is segmented by type into rotarix, rotavac, rotaTeq, rotavin-M1, Lanzhou lamb & others. The market is further segmented by end users into hospitals, clinics, academic & research and others.
Estimates have shown that there is a huge reduction in all-cause diarrhea hospitalizations in high-income countries which ranges from 20 to 50%, in middle-income countries from 17-55% and reduction in rotavirus cases ranging from 49 to 92% in high-income countries, 54 to 59% in middle-income countries and 69 to 81% in low income countries. These estimates show that there would be a significant growth in the rotavirus vaccines market during the forecast period.
North America is anticipated to have leading shares in the global rotavirus vaccines market and U.S. is expected to have major market share owing to the manufacturers in the region launching innovative products in order to cure rotavirus infection among the children. Europe is expected to be the second largest market owing to penetration of high income and health care. Asia Pacific region is anticipated to be the emerging market and experiencing significant growth during the forecast period on account of rise in government initiatives and favorable government laws in the region. Emerging countries are witnessing rise in the prevalence of rotavirus infection which is offering significant growth opportunities to the rotavirus vaccine market.
Increase in Incidents and Support by Organizations
Rotavirus disease is highly transmitted disease and spreads very easily among children owing to their poor hygiene. The rotavirus vaccine is a common problem in clinics and hospitals. Various organizations such as UNICEF and GAVI have supported the adoption of rotavirus vaccine in various countries owing to large scale vaccination and accessing the vaccines at lower prices to reduce the cases of infection and leading to a healthy lifestyle. These are expected to drive the rotavirus vaccine market during the forecast period.
However, high cost and affordability is expected to operate as a key restraint towards the growth of rotavirus vaccines market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the rotavirus vaccines market which includes company profiling of GlaxoSmithKline Plc., Merck & Co. Inc., Bharat Biotech, Sanofi, Lanzhou Institute of Biological Products, and Lanzhou Institute of Biological Products. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the rotavirus vaccines market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.